The risk in buying MU stock isn’t that no one believes in the AI narrative; it’s that everyone does.

While LMT stock appears to be a no-brainer amid escalating tensions in Iran, the options market appears to have efficiently priced this trade.

While ABT stock appears poised to reach the year’s halfway mark in ignominy, the options market is quietly signaling a possible recovery.

While investors are scaling back the AI-at-any-cost narrative, TEM stock brings to the table a highly speculative but enticing bullish trade.

While it’s understandable that traders are betting against NCLH stock amid skepticism, the market may be overestimating the permanence of current stressors.

Nobody really knows where PLTR stock may head next but there is triangulation factor that most traders are ignoring.

Following a 27% YTD loss, most folks would arguably give up on ELF stock. However, the smart money seems to have different ideas.

Although a better-than-expected Q1 earnings print has NVAX stock skyrocketing recently, there’s a high risk in chasing this biotech play.

Although DoorDash’s recent Q1 earnings disclosure seems to have only provided a temporary blip, DASH stock could be due for a more substantive recovery.

Although NXE stock has been a strong performer this year, traders may be tempted to get out while the going is good.